Loading data
MLYSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development expense | 132.01 m USD | 168.58 m USD | 70.36 m USD | 26.25 m USD |
| Operating profit | -170.6 m USD | -192.4 m USD | -84.66 m USD | -31.48 m USD |
| Income tax expense | 0 USD | — | — | — |
| Net income (reported basis) | -154.65 m USD | -177.81 m USD | -71.9 m USD | -29.8 m USD |
| Basic earnings per share | -2.29 USD/share | -3.66 USD/share | -1.99 USD/share | -5.77 USD/share |
| Diluted earnings per share | -2.29 USD/share | -3.66 USD/share | -1.99 USD/share | -5.77 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.